Sue Cammarata

3.5k total citations
58 papers, 2.7k citations indexed

About

Sue Cammarata is a scholar working on Infectious Diseases, Pharmacology and Epidemiology. According to data from OpenAlex, Sue Cammarata has authored 58 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 28 papers in Pharmacology and 22 papers in Epidemiology. Recurrent topics in Sue Cammarata's work include Antimicrobial Resistance in Staphylococcus (32 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Pneumonia and Respiratory Infections (19 papers). Sue Cammarata is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (32 papers), Antibiotics Pharmacokinetics and Efficacy (26 papers) and Pneumonia and Respiratory Infections (19 papers). Sue Cammarata collaborates with scholars based in United States, United Kingdom and Spain. Sue Cammarata's co-authors include Richard G. Wunderink, Marin H. Kollef, Rodney Croos‐Dabrera, Jordi Rello, Thomas H. Oliphant, Laura Lawrence, Eric Rubinstein, Randall Hoover, Eugene Sun and Susan K. Paulson and has published in prestigious journals such as Clinical Infectious Diseases, Environmental Health Perspectives and CHEST Journal.

In The Last Decade

Sue Cammarata

56 papers receiving 2.5k citations

Peers

Sue Cammarata
Steven L. Barriere United States
Philippe Prokocimer United States
Nathalie Dartois France
Rodney Croos‐Dabrera United States
Daniel H. Kett United States
Paula Ramírez Spain
Evelyn J. Ellis‐Grosse United States
Daryl D. DePestel United States
Joyce A. Korvick United States
Barry Hafkin United States
Steven L. Barriere United States
Sue Cammarata
Citations per year, relative to Sue Cammarata Sue Cammarata (= 1×) peers Steven L. Barriere

Countries citing papers authored by Sue Cammarata

Since Specialization
Citations

This map shows the geographic impact of Sue Cammarata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Cammarata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Cammarata more than expected).

Fields of papers citing papers by Sue Cammarata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Cammarata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Cammarata. The network helps show where Sue Cammarata may publish in the future.

Co-authorship network of co-authors of Sue Cammarata

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Cammarata. A scholar is included among the top collaborators of Sue Cammarata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Cammarata. Sue Cammarata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Salata, Robert A., Rodolfo Álvarez-Sala, Juan Pablo Horcajada, et al.. (2019). 2232. A Global Phase 3 Study of Delafloxacin (DLX) Compared with Moxifloxacin (MOX) in Patients with Community-acquired Bacterial Pneumonia (CABP). Open Forum Infectious Diseases. 6(Supplement_2). S762–S762. 1 indexed citations
3.
4.
Hoover, Randall, Harry Alcorn, Laura Lawrence, et al.. (2018). Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment. The Journal of Clinical Pharmacology. 58(6). 814–822. 27 indexed citations
5.
Lodise, Thomas P., Ralph Corey, David C. Hooper, & Sue Cammarata. (2018). Safety of Delafloxacin: Focus on Adverse Events of Special Interest. Open Forum Infectious Diseases. 5(10). ofy220–ofy220. 27 indexed citations
6.
Talbot, George H., Anita Das, Stephanie S. Cush, et al.. (2018). Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. The Journal of Infectious Diseases. 219(10). 1536–1544. 53 indexed citations
7.
Hoover, Randall, et al.. (2018). Pharmacokinetics of Intravenous Delafloxacin in Patients With End‐Stage Renal Disease. The Journal of Clinical Pharmacology. 58(7). 913–919. 14 indexed citations
8.
Dawe, Robert, J. Ferguson, Sally H. Ibbotson, et al.. (2018). Lack of phototoxicity potential with delafloxacin in healthy male and female subjects: comparison to lomefloxacin. Photochemical & Photobiological Sciences. 17(6). 773–780. 21 indexed citations
9.
Hoover, Randall, et al.. (2017). Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function. The Journal of Clinical Pharmacology. 58(4). 514–521. 28 indexed citations
10.
Hoover, Randall, Thomas L. Hunt, Susan K. Paulson, et al.. (2015). Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age. Clinical Therapeutics. 38(1). 39–52. 44 indexed citations
11.
Hoover, Randall, Thomas L. Hunt, Susan K. Paulson, et al.. (2015). Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers. Clinical Therapeutics. 38(1). 53–65. 45 indexed citations
12.
13.
O’Riordan, William, et al.. (2014). A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections. International Journal of Infectious Diseases. 30. 67–73. 86 indexed citations
14.
Kollef, Marin H., Jordi Rello, Sue Cammarata, Rodney Croos‐Dabrera, & Richard G. Wunderink. (2004). Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Medicine. 30(3). 388–394. 243 indexed citations
15.
Wunderink, Richard G., Jordi Rello, Sue Cammarata, Rodney Croos‐Dabrera, & Marin H. Kollef. (2003). Linezolid vs Vancomycin *. CHEST Journal. 124(5). 1789–1797. 242 indexed citations
16.
Wilson, Samuel E., Joseph S. Solomkin, Vu Le, Sue Cammarata, & Jon Bruss. (2003). A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid. The American Journal of Surgery. 185(4). 369–375. 33 indexed citations
17.
Nasraway, Stanley A., et al.. (2003). Linezolid Does Not Increase the Risk of Thrombocytopenia in Patients with Nosocomial Pneumonia: Comparative Analysis of Linezolid and Vancomycin Use. Clinical Infectious Diseases. 37(12). 1609–1616. 69 indexed citations
18.
Miller, J. Philip & Sue Cammarata. (1994). Massive Hemoptysis 17 Years After Repair of Aortic Coarctation. CHEST Journal. 105(4). 1249–1250. 11 indexed citations
19.
Cammarata, Sue, et al.. (1991). Chylothorax After Childbirth. CHEST Journal. 99(6). 1539–1540. 18 indexed citations
20.
Cammarata, Sue, et al.. (1991). Elevated Right Hemidiaphragm with Yellow Sputum Production. CHEST Journal. 99(6). 1463–1465. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven L. Barriere Breakdown of academic impact, for papers by Philippe Prokocimer Breakdown of academic impact, for papers by Nathalie Dartois Breakdown of academic impact, for papers by Rodney Croos‐Dabrera Breakdown of academic impact, for papers by Daniel H. Kett Breakdown of academic impact, for papers by Paula Ramírez Breakdown of academic impact, for papers by Evelyn J. Ellis‐Grosse Breakdown of academic impact, for papers by Daryl D. DePestel Breakdown of academic impact, for papers by Joyce A. Korvick Breakdown of academic impact, for papers by Barry Hafkin
Rankless by CCL
2026